195 related articles for article (PubMed ID: 17932222)
21. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.
Horng T; Barton GM; Flavell RA; Medzhitov R
Nature; 2002 Nov; 420(6913):329-33. PubMed ID: 12447442
[TBL] [Abstract][Full Text] [Related]
22. A unique feature of Toll/IL-1 receptor domain-containing adaptor protein is partially responsible for lipopolysaccharide insensitivity in zebrafish with a highly conserved function of MyD88.
Liu Y; Li M; Fan S; Lin Y; Lin B; Luo F; Zhang C; Chen S; Li Y; Xu A
J Immunol; 2010 Sep; 185(6):3391-400. PubMed ID: 20702732
[TBL] [Abstract][Full Text] [Related]
23. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells.
Paik YH; Schwabe RF; Bataller R; Russo MP; Jobin C; Brenner DA
Hepatology; 2003 May; 37(5):1043-55. PubMed ID: 12717385
[TBL] [Abstract][Full Text] [Related]
24. Reduced hepatic injury in Toll-like receptor 4-deficient mice following D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.
Ben Ari Z; Avlas O; Pappo O; Zilbermints V; Cheporko Y; Bachmetov L; Zemel R; Shainberg A; Sharon E; Grief F; Hochhauser E
Cell Physiol Biochem; 2012; 29(1-2):41-50. PubMed ID: 22415073
[TBL] [Abstract][Full Text] [Related]
25. Spinal toll-like receptor signaling and nociceptive processing: regulatory balance between TIRAP and TRIF cascades mediated by TNF and IFNβ.
Stokes JA; Corr M; Yaksh TL
Pain; 2013 May; 154(5):733-742. PubMed ID: 23489833
[TBL] [Abstract][Full Text] [Related]
26. Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components.
Dobrovolskaia MA; Medvedev AE; Thomas KE; Cuesta N; Toshchakov V; Ren T; Cody MJ; Michalek SM; Rice NR; Vogel SN
J Immunol; 2003 Jan; 170(1):508-19. PubMed ID: 12496438
[TBL] [Abstract][Full Text] [Related]
27. Toll-IL-1 receptor domain-containing adaptor protein is critical for early lung immune responses against Escherichia coli lipopolysaccharide and viable Escherichia coli.
Jeyaseelan S; Manzer R; Young SK; Yamamoto M; Akira S; Mason RJ; Worthen GS
J Immunol; 2005 Dec; 175(11):7484-95. PubMed ID: 16301656
[TBL] [Abstract][Full Text] [Related]
28. Hyaluronan signaling during ozone-induced lung injury requires TLR4, MyD88, and TIRAP.
Li Z; Potts-Kant EN; Garantziotis S; Foster WM; Hollingsworth JW
PLoS One; 2011; 6(11):e27137. PubMed ID: 22073274
[TBL] [Abstract][Full Text] [Related]
29. Bone marrow and nonbone marrow Toll like receptor 4 regulate acute hepatic injury induced by endotoxemia.
Hochhauser E; Avlas O; Fallach R; Bachmetov L; Zemel R; Pappo O; Shainberg A; Ben Ari Z
PLoS One; 2013; 8(8):e73041. PubMed ID: 23977376
[TBL] [Abstract][Full Text] [Related]
30. The TNF family member 4-1BBL sustains inflammation by interacting with TLR signaling components during late-phase activation.
Ma J; Bang BR; Lu J; Eun SY; Otsuka M; Croft M; Tobias P; Han J; Takeuchi O; Akira S; Karin M; Yagita H; Kang YJ
Sci Signal; 2013 Oct; 6(295):ra87. PubMed ID: 24084649
[TBL] [Abstract][Full Text] [Related]
31. Cytoplasmic Linker Protein CLIP170 Negatively Regulates TLR4 Signaling by Targeting the TLR Adaptor Protein TIRAP.
Jakka P; Bhargavi B; Namani S; Murugan S; Splitter G; Radhakrishnan G
J Immunol; 2018 Jan; 200(2):704-714. PubMed ID: 29222167
[TBL] [Abstract][Full Text] [Related]
32. Human cytomegalovirus induces TLR4 signaling components in monocytes altering TIRAP, TRAM and downstream interferon-beta and TNF-alpha expression.
Yew KH; Carpenter C; Duncan RS; Harrison CJ
PLoS One; 2012; 7(9):e44500. PubMed ID: 22970235
[TBL] [Abstract][Full Text] [Related]
33. Dysregulation of LPS-induced Toll-like receptor 4-MyD88 complex formation and IL-1 receptor-associated kinase 1 activation in endotoxin-tolerant cells.
Medvedev AE; Lentschat A; Wahl LM; Golenbock DT; Vogel SN
J Immunol; 2002 Nov; 169(9):5209-16. PubMed ID: 12391239
[TBL] [Abstract][Full Text] [Related]
34. Asparagine attenuates hepatic injury caused by lipopolysaccharide in weaned piglets associated with modulation of Toll-like receptor 4 and nucleotide-binding oligomerisation domain protein signalling and their negative regulators.
Wu H; Liu Y; Pi D; Leng W; Zhu H; Hou Y; Li S; Shi H; Wang X
Br J Nutr; 2015 Jul; 114(2):189-201. PubMed ID: 26079268
[TBL] [Abstract][Full Text] [Related]
35. TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages.
Toshchakov V; Jones BW; Perera PY; Thomas K; Cody MJ; Zhang S; Williams BR; Major J; Hamilton TA; Fenton MJ; Vogel SN
Nat Immunol; 2002 Apr; 3(4):392-8. PubMed ID: 11896392
[TBL] [Abstract][Full Text] [Related]
36. Hepatic and renal cytochrome p450 gene regulation during citrobacter rodentium infection in wild-type and toll-like receptor 4 mutant mice.
Richardson TA; Sherman M; Antonovic L; Kardar SS; Strobel HW; Kalman D; Morgan ET
Drug Metab Dispos; 2006 Mar; 34(3):354-60. PubMed ID: 16339354
[TBL] [Abstract][Full Text] [Related]
37. Toll/IL-1R domain-containing adaptor protein (TIRAP) is a critical mediator of antibacterial defense in the lung against Klebsiella pneumoniae but not Pseudomonas aeruginosa.
Jeyaseelan S; Young SK; Yamamoto M; Arndt PG; Akira S; Kolls JK; Worthen GS
J Immunol; 2006 Jul; 177(1):538-47. PubMed ID: 16785551
[TBL] [Abstract][Full Text] [Related]
38. Longifolioside A inhibits TLR4-mediated inflammatory responses by blocking PKCδ activation in LPS-stimulated THP-1 macrophages.
Lee SU; Oh ES; Ryu HW; Kim MO; Kang MJ; Song YN; Lee RW; Kim DY; Ro H; Jung S; Hong ST; Oh SR
Cytokine; 2020 Jul; 131():155116. PubMed ID: 32388485
[TBL] [Abstract][Full Text] [Related]
39. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.
Yamamoto M; Sato S; Mori K; Hoshino K; Takeuchi O; Takeda K; Akira S
J Immunol; 2002 Dec; 169(12):6668-72. PubMed ID: 12471095
[TBL] [Abstract][Full Text] [Related]
40. Common variants of genes encoding TLR4 and TLR4 pathway members TIRAP and IRAK1 are effective on MCP1, IL6, IL1β, and TNFα levels in type 2 diabetes and insulin resistance.
Degirmenci I; Ozbayer C; Kebapci MN; Kurt H; Colak E; Gunes HV
Inflamm Res; 2019 Sep; 68(9):801-814. PubMed ID: 31222667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
